Aim2
|
Absent in melanoma 2
|
3.32
|
Bcl2l1
|
Bcl2-like 1
|
9.35
|
Birc3
|
Baculoviral IAP repeat-containing 3
|
2.71
|
Casp1
|
Caspase 1
|
3.69
|
Casp12
|
Caspase 12
|
2.32
|
Ccl12
|
Chemokine (C-C motif) ligand 12
|
11.99
|
Ccl5
|
Chemokine (C-C motif) ligand 5
|
53.79
|
Ccl7
|
Chemokine (C-C motif) ligand 7
|
52.00
|
Cd40lg
|
CD40 ligand
|
2.34
|
Ciita
|
Class II transactivator
|
7.31
|
Cxcl1
|
Chemokine (C-X-C motif) ligand 1
|
53.38
|
Cxcl3
|
Chemokine (C-X-C motif) ligand 3
|
11.04
|
Ifnb1
|
Interferon β1, fibroblast
|
19.06
|
Ifng
|
Interferon γ
|
244.50
|
Il12a
|
Interleukin 12A
|
34.22
|
Il1b
|
Interleukin 1β
|
10.22
|
Il6
|
Interleukin 6
|
40.69
|
Irf1
|
Interferon regulatory factor 1
|
5.35
|
Mefv
|
Mediterranean fever
|
3.92
|
Myd88
|
Myeloid differentiation primary response gene 88
|
2.08
|
Naip1
|
NLR family, apoptosis inhibitory protein 1
|
3.20
|
Naip5
|
NLR family, apoptosis inhibitory protein 5
|
8.42
|
Nfkbib
|
Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta
|
16.56
|
Nlrc5
|
NLR family, CARD domain containing 5
|
37.03
|
Nlrp3
|
NLR family, CARD domain containing 3
|
2.95
|
Nlrp4b
|
NLR family, CARD domain containing 4B
|
16.51
|
Nlrp6
|
NLR family, CARD domain containing 6
|
3.43
|
Nod1
|
Nucleotide-binding oligomerization domain containing 1
|
40.81
|
Nod2
|
Nucleotide-binding oligomerization domain containing 2
|
2.64
|
Tnf
|
Tumor necrosis factor
|
10.21
|
Tnfsf11
|
Tumor necrosis factor (ligand) superfamily, member 11
|
164.90
|
Tnfsf14
|
Tumor necrosis factor (ligand) superfamily, member 14
|
2.70
|
| B2m |
Beta-2 microglobulin |
6.55 |
